PG receptors with phosphatase action in cancer and angiogenesis

Extracellular Matrix: Pathobiology and Signaling

Volumn , Issue , 2012, Pages 813-823

  Koutsioumpa, Marina ^a   Papadimitriou, Evangelia ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903538285     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (56)

1. Aricescu, A. R., McKinnell, I. W., Halfter, W., and Stoker, A. W. (2002). Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma. Mol Cell Biol 22, 1881-1892.
2. Ball, M., Carmody, M., Wynne, F., et al. (2009). Expression of pleiotrophin and its receptors in human placenta suggests roles in trophoblast life cycle and angiogenesis. Placenta 30, 649-653.
3. Barcley, A. N., Jackson, D. I. Willis, A. C., and Williams A. F. (1987). Lymphocyte specific heterogeneity in the rat leucocyte common antigen (T200) is due to differences in polypeptide sequences near the NH2-terminus. EMBO J 6, 1259-1264.
4. Barnea, G., Grumet, M., Milev, P., et al. (1994). Receptor tyrosine phosphatase B is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin. J Biol Chem 269, 14349-14352.
5. Barnea, G., Silvennoinen, O., Shaanan, B., et al. (1993). Identification of a carbonic anhydrase-like domain in the extracellular region of RPTP gamma defines a new subfamily of receptor tyrosine phosphatases. Mol Cell Biol 13, 1497-1506.
6. Berman-Golan, D., and Elson, A. (2007). Neu-mediated phosphorylation of protein tyrosine phosphatase epsilon is critical for activation of Src in mammary tumor cells. Oncogene 26, 7028-7037.
7. Carothers, A. M., Melstrom, K. A., Jr., Mueller, J. D., Weyant, M. J., and Bertagnolli, M. M. (2001). Progressive changes in adherens junction structure during intestinal adenoma formation in Apc mutant mice. J Biol Chem 276, 39094-39102.
8. Daum, G., Regenass, R., Sap, J., Schlessinger, J., and Fischer, E. H. (1994). Multiple forms of the human tyrosine phosphatase RPTPalpha. Isozymes and differences in glycosylation. J Biol Chem 269, 10524-10528.
9. Den Hertog, J., Blanchetot, C., Buist, A., Overvoorde, J., van der Sar, A., and Tertoolen, L. G. (1999). Receptor protein-tyrosine phosphatase signalling in development. Int J Dev Biol 43, 723-733.
10. Diamantopoulou, Z., Bermek, O., Polykratis, A., et al. (2010). A pleiotrophin C-terminus peptide induces anti-cancer effects through RPTPß/Z. Mol Cancer. 9, 224.
11. Feng, Z. J., Gao, S. B., Wu, Y., Xu, X. F., Hua, X., and Jin, G. H. (2010). Lung cancer cell migration is regulated via repressing growth factor PTN/RPTP B/Z signaling by menin. Oncogene 29, 5416-5426.
12. Foehr, E. D., Lorente, G., Kuo, J., Ram, R., Nikolich, K., and Urfer, R. (2006). Targeting of the receptor protein tyrosine phosphatase beta with a monoclonal antibody delays tumor growth in a glioblastoma model. Cancer Res 66, 2271-2278.
13. Fujikawa, A., Shirasaka, D., Yamamoto, S., et al. (2003). Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori. Nat Genet 33, 375-381.
14. Goldmann, T., Otto, F., and Vollmer, E. (2000). A receptor-type protein tyrosine phosphatase PTPzeta is expressed in human cutaneous melanomas. Folia Histochem Cytobiol 38, 19-20.
15. Hamma-Kourbali, Y., Bermek, O., Bernard-Pierrot, I., et al. (2011). The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells. BMC Cancer 11, 212.
16. Hausser, H. J., and Brenner, R. E. (2005). Phenotypic instability of Saos-2 cells in long-term culture. Biochem Biophys Res Commun 333, 216-222.
17. He, J., Liu, Y., Xie, X., et al. (2010). Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach. J Proteome Res 9, 2565-2572.
18. Irie-Sasaki, J., Sasaki, T., Matsumoto, W., et al. (2001). CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 409, 349-354.
19. Johnson, K. G., and Van Vactor, D. (2003). Receptor protein tyrosine phosphatases in nervous system development. Physiol Rev 83, 1-24.
20. Koutsioumpa, M., Hatziapostolou, M., Mikelis, C., Koolwijk, P., and Papadimitriou, E. (2009). Aprotinin stimulates angiogenesis and human endothelial cell migration through the growth factor pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta. Eur J Pharmacol 602, 245-249.
21. Krueger, N. X., Streuli, M., and Saito, H. (1990). Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. EMBO J 9, 3241-3252.
22. LaForgia, S., Morse, B., Levy, J., et al. (1991). Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21. Proc Natl Acad Sci U S A 88, 5036-5040.
23. Lazarovits, A. I., Poppema, S., Zhang, Z., et al. (1996). Therapy for mouse renal allograft rejection by monoclonal antibody to CD45RB. Transplant Proc 28, 3208-3209.
24. Liu, S., Sugimoto, Y., Sorio, C., Tecchio, C., and Lin, Y. C. (2004). Function analysis of estrogenically regulated protein tyrosine phosphatase gamma (PTPgamma) in human breast cancer cell line MCF-7. Oncogene 23, 1256-1262.
25. Liu, Y. T., Shang, D., Akatsuka, S., et al. (2007). Chronic oxidative stress causes amplification and overexpression of ptprz1 protein tyrosine phosphatase to activate beta-catenin pathway. Am J Pathol 171, 1978-1988.
26. Lu, K. V., Jong, K. A., Kim, G. Y., et al. (2005). Differential induction of glioblastoma migration and growth by two forms of pleiotrophin. J Biol Chem 280, 26953-26964.
27. Maeda, N., He, J., Yajima, Y., Mikami, T., Sugahara, K., and Yabe, T. (2003). Heterogeneity of the chondroitin sulfate portion of phosphacan/6B4 proteoglycan regulates its binding affinity for pleiotrophin/heparin binding growth-associated molecule. J Biol Chem 278, 35805-35811.
28. Maeda, N., Nishiwaki, T., Shintani, T., Hamanaka, H., and Noda, M. (1996). 6B4 proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphatase Z/ RPTPß, binds pleiotrophin/heparin-binding growth-associated molecule (HBGAM). J Biol Chem 271, 21446-21452.
29. Matozaki, T., Murata, Y., Mori, M., Kotani, T., Okazawa, H., and Ohnishi, H. (2010). Expression, localization, and biological function of the R3 subtype of receptor-type protein tyrosine phosphatases in mammals. Cell Signal 22, 1811-1817.
30. Mikelis, C., Lamprou, M., Koutsioumpa, M., et al. (2011). A peptide corresponding to the C-terminal region of pleiotrophin inhibits angiogenesis /n v/vo and /n v/tro. J Cell Biochem 112, 1532-1543.
31. Mikelis, C., Sfaelou, E., Koutsioumpa, M., Kieffer, N., and Papadimitriou, E. (2009). Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta/zeta. FASEB J 23, 1459-1469.
32. Milev, P., Friedlander, D. R., Sakurai, T., et al. (1994). Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules. J Cell Biol 127, 1703-1715.
33. Milev, P., Monnerie, H., Popp, S., Margolis, R. K., and Margolis, R. U. (1998). The core protein of the chondroitin sulfate proteoglycan phosphacan is a high-affinity ligand of fibroblast growth factor-2 and potentiates its mitogenic activity. J Biol Chem 273, 21439-21442.
34. Muller, S., Kunkel, P., Lamszus, K., et al. (2003). A role for receptor tyrosine phosphatase zeta in glioma cell migration. Oncogene 22, 6661-6668.
35. Muller, T., Choidas, A., Reichmann, E., and Ullrich, A. (1999). Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J Biol Chem 274, 10173-10183.
36. Ostman, A., Yang, Q., and Tonks, N. (1994). Expression of DEP-1, a receptor like proteintyrosine-phosphatase, is enhanced with increasing cell density. Proc Natl Acad Sci U S A 91, 9680-9684.
37. Papadimitriou, E., Mikelis, C., Lampropoulou, E., et al. (2009). Roles of pleiotrophin in tumor growth and angiogenesis. Eur Cytokine Netw 20, 180-190.
38. Perez-Pinera, P., Alcantara, S., Dimitrov, T., Vega, J. A., and Deuel, T. F. (2006). Pleiotrophin disrupts calcium-dependent homophilic cell-cell adhesion and initiates an epithelial-mesenchymal transition. Proc Natl Acad Sci U S A 103, 17795-17800.
39. Perez-Pinera, P., Garcia-Suarez, O., Menendez-Rodriguez, P., et al. (2007). The receptor protein tyrosine phosphatase (RPTP) beta/zeta is expressed in different subtypes of human breast cancer. Biochem Biophys Res Commun 362, 5-10.
40. Polytarchou, C., Hatziapostolou, M., Poimenidi, E., et al. (2009). Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase beta/zeta. Int J Cancer 124, 1785-1793.
41. Qi, M., Ikematsu, S., Maeda, N., et al. (2001). Involvement of protein-tyrosine phosphatase z, mitogen-activates protein kinase, and phosphtidylinositol 3-kinase. J Biol Chem 276, 15868-15875.
42. Ruivenkamp, C. A., van Wezel, L. T., Zanon, C., et al. (2002). Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers. Nat Genet 31, 295-300.
43. Sakaguchi, N., Muramatsu, H., Ichihara-Tanaka, K., et al. (2003). Receptor-type protein tyrosine phosphatase zeta as a component of the signaling receptor complex for midkinedependent survival of embryonic neurons. Neurosci Res 45, 219-224.
44. Sorby, M. (2001). Structural and Functional Studies of the Density Enhanced Receptor-Like Protein Tyrosine Phosphatase DEP-1. Acta Universitatis Upsaliensis. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine.
45. Takahashi, T., Takahashi, K., Mernaugh, R. L., Tsuboi, N., Liu, H., and Daniel, T. O. (2006). A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis. Blood 108, 1234-1242.
46. Thomaidou, D., Coquillat, D., Meintanis, S., Noda, M., Rougon, G., and Matsas, R. (2001). Soluble forms of NCAM and F3 neuronal cell adhesion molecules promote Schwann cell migration: identification of protein tyrosine phosphatases zeta/beta as the putative F3 receptors on Schwann cells. J Neurochem 78, 767-778.
47. Thompson, L. J., Jiang, J., Madamanchi, N., Runge, M. S., and Patterson, C. (2001). PTP-epsilon, a tyrosine phosphatase expressed in endothelium, negatively regulates endothelial cell proliferation. Am J Physiol Heart Circ Physiol 281, 396-403.
48. Toledano-Katchalski, H., Kraut, J., Sines, T., et al. (2003). Protein tyrosine phosphatase epsilon inhibits signaling by mitogen-activated protein kinases. Mol Cancer Res 1, 541-550.
49. Tong, Y., Mentlein, R., Buhl, R., et al. (2006). Overexpression of midkine contributes to antiapoptotic effects in human meningiomas. J Neurochem 100, 1097-1107.
50. Ulbricht, U., Brockmann, M. A., Aigner, A., et al. (2003). Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas. J Neuropathol Exp Neurol 62, 1265-1275.
51. Ulbricht, U., Eckerich, C., Fillbrandt, R., Westphal, M., and Lamszus, K. (2006). RNA interference targeting protein tyrosine phosphatase Z/receptor-type protein tyrosine phosphatase B suppresses glioblastoma growth /n v/tro and /n v/vo. J Neurochem 98, 1497-1506.
52. Van Niekerk, C. C., and Poels, L. G. (1999). Reduced expression of protein tyrosine phosphatase gamma in lung and ovarian tumors. Cancer Lett 137, 61-73.
53. Wang, V., Davis, D. A., Veeranna, R. P., Haque, M., and Yarchoan, R. (2010). Characterization of the activation of protein tyrosine phosphatase, receptor-type, Z polypeptide 1 (PTPRZ1) by hypoxia inducible factor-2 alpha. PLoS One 5, e9641.
54. Wang, W. J., Kuo, J. C., Ku, W., et al. (2007). The tumor suppressor DAPK is reciprocally regulated by tyrosine kinase Src and phosphatase LAR. Mol Cell 27, 701-716.
55. Wu, M., Gan, K., Huang, C., et al. (2006). LRRC4 controls n v tro invasion of glioblastoma cells through inhibiting RPTP-zeta expression. J Neurooncol 80, 133-142.
56. Zheng, W., Lennartsson, J., Hendriks, W., Heldin, C. H., and Hellberg, C. (2011). The LAR protein tyrosine phosphatase enables PDGF B-receptor activation through attenuation of the c-Abl kinase activity. Cell Signal 23, 1050-1056.